May 15, 2019
Powles T et al. Nature Medicine 2019;25:1706–1714.
Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial
You might also be interested by
Scientific Publications
Final Results of Neoadjuvant Atezolizumab in Cisplatin-ineligible Patients with Muscle-invasive Urothelial Cancer of the Bladder
July 18, 2022
Histopathology
More infoWeb News
CellCarta Launches Advanced AI-Powered Spatial Biology Data for Clinical Trials
March 1, 2022
Histopathology
More info